Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
AI in Dermatology: Augmenting Diagnosis, Prognosis, and Clinical Workflow
Description
The speaker, a dermatologist and informatics researcher, argues that AI’s role in dermatology is to augment—not replace—clinicians by improving accuracy, efficiency, and workflow while keeping the dermatologist in the loop. He reviews how AI entered dermatology through dermoscopy and digital photography, noting that models can match or outperform inexperienced clinicians and sometimes improve clinician accuracy when used as decision support. He highlights current FDA-approved triage tools, total body photography systems, and newer foundation models trained on skin-specific data that can diagnose and explain findings better than general models. The talk then shifts to clinical decision support, especially melanoma prognostication, where combining EHR data, pathology images, and clinical features improves recurrence prediction and risk stratification beyond standard staging. He also describes multi-agent AI systems for tumor boards and emphasizes that operations management is the most common current use of AI, especially ambient scribing, patient intake, scheduling, and automated patient communication, which reduce documentation burden and burnout. Overall, he concludes that multi-modal AI will increasingly support dermatology by improving diagnosis, prognosis, productivity, and access to expert-level care.
View moreConclusions
- AI is becoming routine in dermatology, especially for image analysis, and its use is rising quickly among clinicians.
- For standardized skin imaging tasks like dermoscopy and total body photography, AI can match or sometimes exceed average dermatologist performance, particularly when image quality and capture conditions are controlled.
- AI works best as a clinician-in-the-loop tool, where it supports rather than replaces dermatologists and can modestly improve diagnostic accuracy and decision-making.
- Skin-specific foundation models trained on dermatology data outperform general-purpose models, especially for focused tasks such as melanoma detection and explanation.
- Multi-modal models that combine imaging, pathology, and clinical/EHR data perform better than single-modality approaches for many dermatology problems.
- For melanoma recurrence prediction, AI models using EHR and histopathology data outperform AJCC staging alone and can identify low-, intermediate-, and high-risk groups more effectively.
- The strongest prognostic systems are those that integrate clinical, imaging, and pathology information, since each modality contributes independent predictive value.
- AI can support tumor board-style reasoning and treatment selection with high agreement to expert oncologist recommendations, suggesting a path to more standardized and democratized expert guidance.
- The most immediate and widespread benefits of AI in practice come from operations management, especially ambient scribing, patient intake, scheduling, and clinical text generation.
- AI tools can meaningfully reduce documentation burden, after-hours work, and administrative costs, which may also help reduce clinician burnout and improve workflow efficiency.
- Li Z, et al, Journal of Clinical Medicine Research 11 (22).
- Codella N, et al., ISIC Competition 2018.
- Pham TC et al., Sci Rep 11, 17485 (2021).
- Brinker TJ et al., Eur J Cancer. 2019 Apr;111:30–37.
- Du-Harpur X, et al., Br J Dermatol. 2020 Sep;183(3):423-430.
- Zhou, J., et al. Nat Commun 15, 5649 (2024).
- Yan, S., et al. Nat Med 31, 2691–2702 (2025).
- Arevalo J, et al., Artificial Intelligence in Medicine 64 (2): 131–45.
- Wan G, et al. NPJ Precis Oncol. 2022 Oct 31;6(1):79.
- Wan G, et al., J Am Acad Dermatol. 2024 Feb;90(2):288-298.
- Wang G et al. NPJ Precis Oncol. 2022 Oct 31;6(1):79.
- Wang J. at the 2025 ASCO Annual Meeting.
- Jun H. et al. in Cancer Cell, 2026.
- Tu T., et al., arXiv:2401.05654.